{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:46:38Z","timestamp":1761061598295,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00330-022-08655-0","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T07:02:48Z","timestamp":1646463768000},"page":"5752-5758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-2094","authenticated-orcid":false,"given":"Joao V.","family":"Horvat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varadan","family":"Sevilimedu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton S.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Perez-Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly N.","family":"Feigin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"8655_CR1","doi-asserted-by":"publisher","first-page":"102887","DOI":"10.1016\/j.ebiom.2020.102887","volume":"58","author":"P Domingo","year":"2020","unstructured":"Domingo P, Mur I, Pomar V, Corominas H, Casademont J, de Benito N (2020) The four horsemen of a viral Apocalypse: the pathogenesis of SARS-CoV-2 infection (COVID-19). EBioMedicine 58:102887","journal-title":"EBioMedicine"},{"key":"8655_CR2","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/S1473-3099(20)30923-3","volume":"21","author":"JA Singh","year":"2021","unstructured":"Singh JA, Upshur REG (2021) The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials. Lancet Infect Dis 21:e103\u2013e109","journal-title":"Lancet Infect Dis"},{"key":"8655_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A et al (2021) Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 21:939\u2013949","journal-title":"Lancet Infect Dis"},{"key":"8655_CR4","unstructured":"Pfizer-BioNTech COVID-19 Vaccine. United States Food and Drug Administration. Available via https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/pfizer-biontech-covid-19-vaccine. Accessed 21 June 2021"},{"key":"8655_CR5","unstructured":"Moderna COVID-19 Vaccine. United States Food and Drug Administration. Available via https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/moderna-covid-19-vaccine. Accessed 21 June 2021"},{"key":"8655_CR6","unstructured":"Janssen COVID-19 Vaccine. United States Food and Drug Administration. Available via https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/janssen-covid-19-vaccine. Accessed 21 June 2021"},{"key":"8655_CR7","unstructured":"Agency EM COVID-19 Vaccines. Available via https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/covid-19-vaccines. Accessed 16 Jan 2022"},{"key":"8655_CR8","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/jama.2021.3199","volume":"325","author":"CB Creech","year":"2021","unstructured":"Creech CB, Walker SC, Samuels RJ (2021) SARS-CoV-2 Vaccines. JAMA 325:1318\u20131320","journal-title":"JAMA"},{"key":"8655_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA 318:918\u2013926","journal-title":"JAMA"},{"key":"8655_CR10","doi-asserted-by":"publisher","unstructured":"Mamounas EP, Kuehn T, Rutgers EJT, von Minckwitz G (2017) Current approach of the axilla in patients with early-stage breast cancer. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(17)31451-4","DOI":"10.1016\/S0140-6736(17)31451-4"},{"key":"8655_CR11","unstructured":"Local reactions, systemic reactions, adverse events, and serious adverse events: Pfizer-BioNTech COVID-19 Vaccine. Centers for Disease Control and Prevention. Available via https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/reactogenicity.html. Accessed 21 June 2021"},{"key":"8655_CR12","unstructured":"Local reactions, systemic reactions, adverse events, and serious adverse events: Moderna COVID-19 Vaccine. Centers for Disease Control and Prevention. Available via https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/moderna\/reactogenicity.html. Accessed 21 June 2021"},{"key":"8655_CR13","doi-asserted-by":"publisher","unstructured":"Lehman CD, Lamb LR, D'Alessandro HA (2021) Mitigating the impact of coronavirus disease (COVID-19) vaccinations on patients undergoing breast imaging examinations: a pragmatic approach. AJR Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.21.25688","DOI":"10.2214\/AJR.21.25688"},{"key":"8655_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384:403\u2013416","journal-title":"N Engl J Med"},{"key":"8655_CR15","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603\u20132615","journal-title":"N Engl J Med"},{"key":"8655_CR16","doi-asserted-by":"publisher","unstructured":"Becker AS, Perez-Johnston R, Chikarmane SA et al (2021) Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: Radiology Scientific Expert Panel. Radiology. https:\/\/doi.org\/10.1148\/radiol.2021210436:210436","DOI":"10.1148\/radiol.2021210436:210436"},{"key":"8655_CR17","doi-asserted-by":"publisher","first-page":"E296","DOI":"10.1148\/radiol.2021210275","volume":"300","author":"C Ozutemiz","year":"2021","unstructured":"Ozutemiz C, Krystosek LA, Church AL et al (2021) Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients. Radiology 300:E296\u2013E300","journal-title":"Radiology"},{"key":"8655_CR18","doi-asserted-by":"publisher","unstructured":"Seely JM, Barry MH (2021) The Canadian Society of Breast Imaging\/ Canadian Association of Radiologists\u2019 Recommendations for the Management of Axillary Adenopathy in Patients With Recent COVID-19 Vaccination. Can Assoc Radiol J. https:\/\/doi.org\/10.1177\/0846537121998949:846537121998949","DOI":"10.1177\/0846537121998949:846537121998949"},{"key":"8655_CR19","unstructured":"Grimm L, Destounis S, Dogan B et al SBI recommendations for the management of axillary adenopathy in patients with recent COVID-19 vaccination. Society of Breast Imaging. Available via https:\/\/www.sbi-online.org\/Portals\/0\/Position%20Statements\/2021\/SBI-recommendations-for-managing-axillary-adenopathy-post-COVID-vaccination.pdf. Accessed 21 June 2021"},{"key":"8655_CR20","doi-asserted-by":"publisher","unstructured":"Mortazavi S (2021) Coronavirus Disease (COVID-19) Vaccination associated axillary adenopathy: imaging findings and follow-up recommendations in 23 women. AJR Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.21.25651","DOI":"10.2214\/AJR.21.25651"},{"key":"8655_CR21","doi-asserted-by":"publisher","unstructured":"Edmonds CE, Zuckerman SP, Conant EF (2021) Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of coronavirus disease (COVID-19) vaccination. AJR Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.21.25604","DOI":"10.2214\/AJR.21.25604"},{"key":"8655_CR22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jacr.2021.03.001","volume":"18","author":"CD Lehman","year":"2021","unstructured":"Lehman CD, D'Alessandro HA, Mendoza DP, Succi MD, Kambadakone A, Lamb LR (2021) Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties. J Am Coll Radiol 18:843\u2013852","journal-title":"J Am Coll Radiol"},{"key":"8655_CR23","doi-asserted-by":"publisher","unstructured":"Brown A, Shah S, Dluzewski S et al (2021) Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines. Clin Radiol. https:\/\/doi.org\/10.1016\/j.crad.2021.04.010","DOI":"10.1016\/j.crad.2021.04.010"},{"key":"8655_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.clinimag.2021.01.016","volume":"75","author":"N Mehta","year":"2021","unstructured":"Mehta N, Sales RM, Babagbemi K et al (2021) Unilateral axillary adenopathy in the setting of COVID-19 vaccine. Clin Imaging 75:12\u201315","journal-title":"Clin Imaging"},{"key":"8655_CR25","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00259-021-05314-2","volume":"48","author":"D Cohen","year":"2021","unstructured":"Cohen D, Krauthammer SH, Wolf I, Even-Sapir E (2021) Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging 48:1854\u20131863","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8655_CR26","doi-asserted-by":"publisher","unstructured":"Eifer M, Tau N, Alhoubani Y et al (2021) Covid-19 mRNA vaccination: age and immune status and its association with axillary lymph node PET\/CT uptake. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.121.262194","DOI":"10.2967\/jnumed.121.262194"},{"key":"8655_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13244-021-01062-x","volume":"12","author":"S Schiaffino","year":"2021","unstructured":"Schiaffino S, Pinker K, Magni V et al (2021) Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI). Insights Imaging 12:119","journal-title":"Insights Imaging"},{"key":"8655_CR28","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1245\/s10434-017-5965-5","volume":"24","author":"DP McCartan","year":"2017","unstructured":"McCartan DP, Zabor EC, Morrow M, Van Zee KJ, El-Tamer MB (2017) Oncologic outcomes after treatment for MRI occult breast cancer (pT0N+). Ann Surg Oncol 24:3141\u20133147","journal-title":"Ann Surg Oncol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08655-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-022-08655-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08655-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T21:38:11Z","timestamp":1657748291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-022-08655-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["8655"],"URL":"https:\/\/doi.org\/10.1007\/s00330-022-08655-0","relation":{},"ISSN":["1432-1084"],"issn-type":[{"type":"electronic","value":"1432-1084"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"3 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Joao V. Horvat, MD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: Dr. Kimberly N Feigin is a paid clinical advisor to Covera Health, Inc. The company had no participation in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (Varadan Sevilimedu) has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 observational\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}